Engineering and Development

Founder, President and CEO

Chief Financial Officer

Nuvation Bio Reports Third Quarter 2025 Financial Results and Provides Business Update

Transcript : Nuvation Bio Inc., Q3 2025 Earnings Call, Nov 03, 2025

Nuvation Bio reports Q3 EPS (16c), one estimate (15c)

Nuvation Bio options imply 19.2% move in share price post-earnings

Director, Clinical Data Management

Nuvation Bio is a biopharmaceutical company focused on developing innovative therapies for oncology. They are seeking a Director of Clinical Data Management to lead data management activities for clinical trials, ensuring collaboration with various stakeholders and maintaining data quality throughout the study lifecycle.

REQ 0243 Dir., Clinical Data Management

VP, Total Rewards and People Operations

Sign up with Google

Sign in with Google